BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36628054)

  • 1. Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional Survey.
    van Wijhe M; Fogh K; Ethelberg S; Karmark Iversen K; Nielsen H; Østergaard L; Andersen B; Bundgaard H; Jørgensen CS; Scharff BFS; Ellermann-Eriksen S; Johansen IS; Fomsgaard A; Grove Krause T; Wiese L; Fischer TK; Mølbak K; Benfield T; Folke F; Lippert F; Ostrowski SR; Koch A; Erikstrup C; Vangsted AM; Sørensen AIV; Ullum H; Skov RL; Simonsen L; Nielsen SD
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac679. PubMed ID: 36628054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls.
    Sandmann FG; Tessier E; Lacy J; Kall M; Van Leeuwen E; Charlett A; Eggo RM; Dabrera G; Edmunds WJ; Ramsay M; Campbell H; Amirthalingam G; Jit M
    Clin Infect Dis; 2022 Aug; 75(1):e962-e973. PubMed ID: 35245941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents.
    Messiah SE; Hao T; DeSantis SM; Swartz MD; Talebi Y; Kohl HW; Zhang S; Valerio-Shewmaker M; Yaseen A; Kelder SH; Ross J; Gonzalez MO; Wu L; Padilla LN; Lopez KR; Lakey D; Shuford JA; Pont SJ; Boerwinkle E
    Pediatr Infect Dis J; 2022 Oct; 41(10):e409-e417. PubMed ID: 35939608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN).
    Haberland E; Haberland J; Richter S; Schmid M; Hromek J; Zimmermann H; Geng S; Winterer H; Schneider S; Kollum M
    Int J Clin Pract; 2022; 2022():8373697. PubMed ID: 36035510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
    Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
    JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.
    Johannesen CK; Rezahosseini O; Gybel-Brask M; Kristensen JH; Hasselbalch RB; Pries-Heje MM; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Jensen CAJ; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Dessau RB; Sørensen E; Harritshøj LH; Folke F; Sten C; Møller MEE; Engsig FN; Ullum H; Jørgensen CS; Ostrowski SR; Bundgaard H; Iversen KK; Fischer TK; Nielsen SD
    Microbiol Spectr; 2021 Oct; 9(2):e0090421. PubMed ID: 34668738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms in the acute phase of SARS-CoV-2 infection among Danish children aged 0-14 years.
    Berg SK; Palm P; Nielsen SD; Nygaard U; Bundgaard H; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Petersen MNS; Christensen AV
    IJID Reg; 2023 Jun; 7():262-267. PubMed ID: 37200560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study.
    Aabakke AJM; Krebs L; Petersen TG; Kjeldsen FS; Corn G; Wøjdemann K; Ibsen MH; Jonsdottir F; Rønneberg E; Andersen CS; Sundtoft I; Clausen T; Milbak J; Burmester L; Lindved B; Thorsen-Meyer A; Khalil MR; Henriksen B; Jønsson L; Andersen LLT; Karlsen KK; Pedersen ML; Klemmensen Å; Vestgaard M; Thisted D; Tatla MK; Andersen LS; Brülle AL; Gulbech A; Andersson CB; Farlie R; Hansen L; Hvidman L; Sørensen AN; Rathcke SL; Rubin KH; Petersen LK; Jørgensen JS; Stokholm L; Bliddal M
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2097-2110. PubMed ID: 34467518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.
    Lund LC; Hallas J; Nielsen H; Koch A; Mogensen SH; Brun NC; Christiansen CF; Thomsen RW; Pottegård A
    Lancet Infect Dis; 2021 Oct; 21(10):1373-1382. PubMed ID: 33984263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.
    Hirschtick JL; Titus AR; Slocum E; Power LE; Hirschtick RE; Elliott MR; McKane P; Fleischer NL
    Clin Infect Dis; 2021 Dec; 73(11):2055-2064. PubMed ID: 34007978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19.
    Boscolo-Rizzo P; Borsetto D; Fabbris C; Spinato G; Frezza D; Menegaldo A; Mularoni F; Gaudioso P; Cazzador D; Marciani S; Frasconi S; Ferraro M; Berro C; Varago C; Nicolai P; Tirelli G; Da Mosto MC; Obholzer R; Rigoli R; Polesel J; Hopkins C
    JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):729-732. PubMed ID: 32614442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study.
    Izquierdo-Domínguez A; Rojas-Lechuga MJ; Chiesa-Estomba C; Calvo-Henríquez C; Ninchritz-Becerra E; Soriano-Reixach M; Poletti-Serafini D; Villarreal IM; Maza-Solano JM; Moreno-Luna R; Villarroel PP; Mateos-Serrano B; Agudelo D; Valcarcel F; Del Cuvillo A; Santamaría A; Mariño-Sánchez F; Aguilar J; Vergés P; Inciarte A; Soriano A; Mullol J; Alobid I
    J Investig Allergol Clin Immunol; 2020; 30(5):346-357. PubMed ID: 32554337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treated post-acute sequelae after COVID-19 in a German matched cohort study using routine data from 230,256 adults.
    Müller D; Stengel S; Roesler M; Schillinger G; Dräther H; Günster C; Tillmanns H; Erhart M; Szecsenyi J; Merle U
    Front Epidemiol; 2022; 2():1089076. PubMed ID: 38455320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
    PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens.
    Rømer V; Sivapalan P; Eklöf J; Nielsen SD; Harboe ZB; Biering-Sørensen T; Itenov T; Jensen JS
    Eur Psychiatry; 2023 Jun; 66(1):e50. PubMed ID: 37282564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.